Logo Lanfrica
  • Home
  • Atlas
  • Insights
  • Docs
  • Sign in

© 2026 Lanfrica. All rights reserved. All copyrights of the resources shown on the Lanfrica website belong to the original copyright holders, unless explicitly stated otherwise.

Using quality improvement to accelerate highly active antiretroviral treatment coverage in South Africa

Domain:

healthcare

Record type:

dataset
Creator:
PatMarDinKed
Publisher:
BMJ
Host:
Introduction The authors report on a health systems strengthening intervention using quality improvement (QI) methods at the subdistrict level to accelerate highly active antiretroviral treatment (HAART) initiation in South Africa. Methods Using a phased scale-up design between August 2006 and November 2009, 14 primary healthcare clinics, one community health centre, one district hospital and one tertiary hospital in a subdistrict were recruited into a ‘learning network’ using QI methods to facilitate cross-facility learning/mentorship/support. Clinic teams consisting of nurses, counsellors, clerks and/or doctors set collective and individual performance targets, analysed their care systems using ‘real-time’ data feedback, and designed/implemented a set of simple changes to improve HIV testing and HAART initiation rates across the region. Data analysis Primary clinic data were used to measure HAART initiation rates (primary outcome) and HIV testing (secondary outcome). We analysed data variation/trends using an interrupted time series design. Logistic regression analysis was applied to examine trends in HAART initiation during the intervention phases. Results Clinics in the learning network increased HIV testing by 301.8% from 891/month (SD=94.2) to 3580/month (SD=327.7) (p<0.0001). Monthly HAART initiations increased by 185.5% from 179/month (SD=17.22) to 511/month (SD=44.93) (p<0.0001). During the pilot (phase I), the monthly rate of HAART initiations increased by 3.6 patients. In the prototype collaborative (phase II), there was no acceleration in the rate of increase (3.3/month, p=0.92). Significant acceleration was observed in the rate of increase during the QI scale up (phase III) (10.1/month, p<0.001). The proportion of estimated need for HAART met in the region increased from 35.8% to 72.4% at a time of rapid population growth. Conclusion A QI approach, using learning networks to teach simple data-driven methods for addressing system failures, with increased training and resource inputs, can assist districts to quickly reach universal coverage targets.

Visit

doi.org

Similar

Evaluation of Treatment Outcomes Among Individuals on Highly Active Antiretroviral Therapy in KwaZulu‐Natal, South AfricaWhen to Initiate Highly Active Antiretroviral Therapy in Sub-Saharan Africa? A South African Cost-Effectiveness StudyValidation and Improvement of a Machine Learning Model to Predict Interruptions in Antiretroviral Treatment in South AfricaRate and predictors of Treatment Failure among pediatric population taking Highly Active Antiretroviral Therapy in EthiopiaPharmacovigilance of highly active antiretroviral therapy among adult patients in a large urban HIV treatment center in NigeriaEffectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga District Hospital in 2007

Evaluation of Treatment Outcomes Among Individuals on Highly Active Antiretroviral Therapy in KwaZulu‐Natal, South Africa

Despite access to antiretroviral therapy (ART), South Africa has a high human immunodeficiency virus

When to Initiate Highly Active Antiretroviral Therapy in Sub-Saharan Africa? A South African Cost-Effectiveness Study

Background Large-scale programmes increasing access to highly active antiretro

Validation and Improvement of a Machine Learning Model to Predict Interruptions in Antiretroviral Treatment in South Africa

Introduction: Machine learning algorithms are increasingly being used to inform HIV pr

Rate and predictors of Treatment Failure among pediatric population taking Highly Active Antiretroviral Therapy in Ethiopia

Abstract Background Though the unprecedent

Pharmacovigilance of highly active antiretroviral therapy among adult patients in a large urban HIV treatment center in Nigeria

Effectiveness of anti-tuberculosis treatment among patients receiving highly active antiretroviral therapy at Vihiga District Hospital in 2007